Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Erenumab in chronic migraine: Experience from a UK tertiary centre and comparison with other real‐world evidence
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-21
DOI
10.1111/ene.15364
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
- (2020) Raffaele Ornello et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
- (2020) Bianca Raffaelli et al. Frontiers in Neurology
- Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?
- (2020) David Moreno-Ajona et al. CURRENT OPINION IN NEUROLOGY
- A prospective real-world analysis of erenumab in refractory chronic migraine
- (2020) Giorgio Lambru et al. JOURNAL OF HEADACHE AND PAIN
- Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
- (2020) Armin Scheffler et al. JOURNAL OF HEADACHE AND PAIN
- Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine
- (2020) Jennifer Robblee et al. HEADACHE
- One year experience with erenumab: real-life data in 30 consecutive patients
- (2020) Angelo Ranieri et al. NEUROLOGICAL SCIENCES
- Erenumab in chronic migraine with medication overuse
- (2019) Stewart J. Tepper et al. NEUROLOGY
- Current and emerging evidence-based treatment options in chronic migraine: a narrative review
- (2019) Elio Clemente Agostoni et al. JOURNAL OF HEADACHE AND PAIN
- Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study
- (2018) Messoud Ashina et al. CEPHALALGIA
- ARISE: A Phase 3 randomized trial of erenumab for episodic migraine
- (2018) David W Dodick et al. CEPHALALGIA
- Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
- (2018) CEPHALALGIA
- Monoclonal antibodies for migraine: an update
- (2018) Daniel Castle et al. JOURNAL OF NEUROLOGY
- Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study
- (2018) Uwe Reuter et al. LANCET
- Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
- (2017) Stewart Tepper et al. LANCET NEUROLOGY
- A Controlled Trial of Erenumab for Episodic Migraine
- (2017) Peter J. Goadsby et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing Barriers to Chronic Migraine Consultation, Diagnosis, and Treatment: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study
- (2016) David W. Dodick et al. HEADACHE
- Adherence to oral migraine-preventive medications among patients with chronic migraine
- (2014) Zsolt Hepp et al. CEPHALALGIA
- A comparative study of candesartan versus propranolol for migraine prophylaxis: A randomised, triple-blind, placebo-controlled, double cross-over study
- (2013) Lars J Stovner et al. CEPHALALGIA
- Disability, HRQoL and resource use among chronic and episodic migraineurs: Results from the International Burden of Migraine Study (IBMS)
- (2010) AM Blumenfeld et al. CEPHALALGIA
- Chronic Migraine: Epidemiology and Disease Burden
- (2010) Aubrey N. Manack et al. Current Pain and Headache Reports
- OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program
- (2010) David W. Dodick et al. HEADACHE
- CGRP and its receptors provide new insights into migraine pathophysiology
- (2010) Tony W. Ho et al. Nature Reviews Neurology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More